TIL - Instil Bio, Inc.
8.055
-0.125 -1.552%
Share volume: 23,677
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$8.18
-0.13
-0.02%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-04-2025 | 05-13-2025 | 11-13-2025 | 03-27-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | ||||
| Operating expenses | 11.472 M | 14.480 M | 15.022 M | 9.557 M | |
| Selling general and admin | 10.373 M | 9.109 M | 5.895 M | 6.060 M | |
| Research and development | 1.099 M | 5.371 M | 9.127 M | 3.497 M | |
| Total expenses | 11.820 M | 30.562 M | 15.022 M | 9.557 M | |
| 158.56% | -50.85% | -36.38% | |||
| Operating income | -11.820 M | -30.562 M | -15.022 M | -9.557 M | |
| Ebit | -13.016 M | -30.519 M | -15.140 M | -9.612 M | |
| Pretax income | -11.895 M | -28.200 M | -13.587 M | -8.191 M | |
| 137.07% | -51.82% | -39.71% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.895 M | -28.200 M | -13.587 M | -8.191 M | |
| -137.07% | 51.82% | 39.71% |